Precision Biopsy: Precision Biopsy set to speed commercialization of optical fiber-driven biopsy system for prostate cancer
An optical fiber-driven system for real-time classification of prostate cancer during biopsies has raised $33.6 million in new funding.
Read full article »Est. Annual Revenue
Est. Employees
CEO
Amir Tehrani
Precision Biopsy develops optical biopsy devices to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. Read more
